Inhibition constants, inhibitor concentrations and the prediction of inhibitory drug drug interactions: pitfalls, progress and promise.
about
Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agentsUse of simple docking methods to screen a virtual library for heteroactivators of cytochrome P450 2C9.Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions.Inhibition of human liver aldehyde oxidase: implications for potential drug-drug interactions.Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) modelsChemical proteomic probes for profiling cytochrome p450 activities and drug interactions in vivo.Application of chimeric mice with humanized liver for predictive ADME.Cytochrome P450 reaction-phenotyping: an industrial perspective.Sources of variability in ketoconazole inhibition of human cytochrome P450 3A in vitro.Metabolic-based drug-drug interactions prediction, recent approaches for risk assessment along drug development.Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoconazole interaction in rats.Effect of cinacalcet hydrochloride, a new calcimimetic agent, on the pharmacokinetics of dextromethorphan: in vitro and clinical studies.
P2860
Q28201362-7F972FBE-28E1-4C60-9B21-134F864E78FAQ33274718-E63E02C4-0EBC-4E7B-B999-868D60A199A3Q34190909-CA7BB06A-223B-4C36-AF3F-6939792493A1Q35579544-44E945E0-58D2-4CCF-92CB-AC167F0B627EQ35753588-C2139024-4065-4FB6-949B-29E970D22CB8Q36097183-616E5A8D-613F-4E40-8CBA-41857C45E779Q36761682-C41A35A5-4553-4C10-8FEE-A20B81C80CFCQ36960539-86750421-1FFA-4107-8404-BF4EBC819EFAQ37780212-E0ABA4F4-FF63-4F26-B1D2-F2FF3D9968AEQ37965706-4039CEA4-6FC9-4707-A626-8972E5E36AC5Q48163670-C73643CA-30EB-4098-BF90-DA2E36858BB9Q53538620-1F5825C4-5148-425D-A6B2-C2B5F7C31BFD
P2860
Inhibition constants, inhibitor concentrations and the prediction of inhibitory drug drug interactions: pitfalls, progress and promise.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Inhibition constants, inhibito ...... itfalls, progress and promise.
@ast
Inhibition constants, inhibito ...... itfalls, progress and promise.
@en
type
label
Inhibition constants, inhibito ...... itfalls, progress and promise.
@ast
Inhibition constants, inhibito ...... itfalls, progress and promise.
@en
prefLabel
Inhibition constants, inhibito ...... itfalls, progress and promise.
@ast
Inhibition constants, inhibito ...... itfalls, progress and promise.
@en
P1476
Inhibition constants, inhibito ...... itfalls, progress and promise.
@en
P2093
Bachmann KA
P356
10.2174/138920006774832541
P407
P577
2006-01-01T00:00:00Z